Date & Time of Session - 10/24/25 - from 12:00 - 1:00PM

Overview
As BTE (bispecific T-cell engager) therapies expand beyond hematologic malignancies into solid tumors, pharmacists are increasingly integral to optimizing their safe and effective use. These agents present unique challenges, including cytokine release syndrome and neurotoxicity, which require vigilant monitoring and proactive management. Additionally, evolving strategies to transition BTE therapies from inpatient to outpatient settings demand careful coordination and clinical oversight. Continuing education for pharmacists is essential to equip them with the knowledge and skills needed to support safe administration, monitor for adverse events, and enhance patient outcomes in this rapidly advancing therapeutic area.

Objectives
Upon completion of this activity, participants will be able to:
1. Explain the mechanism of action and immunologic principles underlying bispecific T-cell engager (BTE) therapies. 
2. Evaluate major clinical trials investigating BTE therapies in solid tumors. 
3. Develop strategies to recognize, prevent, and manage acute toxicities associated with BTE therapies. 
4. Assess logistical, clinical, and safety considerations for transitioning BTE therapy administration from the inpatient to outpatient setting.

    Target Audience
    Pharmacists, residents, and students

    Special Services
    If you require special assistance to attend this event, please call Megan Russell at (304) 550-0896.

    Speaker:
    Megan Russell, PharmD
    PGY2 Hematology/Oncology Pharmacy Resident
    UK College of Pharmacy - Lexington, Kentucky

    Session date: 
    10/24/2025 - 12:00pm EDT to 12/22/2025 - 11:59pm EST
    Add to calendar: 
    • 1.00 ACPE

      In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

      This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

    • 1.00 Participation
      UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
    Please login or register to take this course.
    Faculty List: 
    Speaker(s)

    Megan Russell, PharmD

    has no relevant financial relationships to disclose at this time.